Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Holders of 5% or more of ALGS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aligos Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 13G | 9.99%530.0K shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
| Blatt Lawrence | 13D | 5.60%316.2K shares | +0.50 ppfrom 5.10% | Feb 11, 20216 filings | Jun 24, 2026 | SEC |
| Sio Capital Management, LLC | 13G/A | 5.46%335.9K shares | −0.03 ppfrom 5.49% | Aug 13, 20252 filings | Feb 11, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
41 Schedule 13D and 13G filings on Aligos Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 24, 20264:30 PM ET | Blatt Lawrence | 13D | 5.60%316.2K shares | +0.50 ppfrom 5.10% | Jun 16, 2026 | SEC |
| May 15, 20264:30 PM ET | Blatt Lawrence | 13G | 5.10%286.2K shares | +1.90 ppfrom 3.20% | Mar 31, 2026 | SEC |
| May 15, 20269:05 AM ET | Woodline Partners LP | 13G/A | 4.40%239.4K shares | −1.00 ppfrom 5.40%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 20263:22 PM ET | Woodline Partners LP | 13G/A | 5.40%289.2K shares | −3.30 ppfrom 8.70% | Dec 31, 2025 | SEC |
| Feb 11, 20264:32 PM ET | Sio Capital Management, LLC | 13G/A | 5.46%335.9K shares | −0.03 ppfrom 5.49% | Dec 31, 2025 | SEC |
| Nov 14, 20254:15 PM ET | Woodline Partners LP | 13G/A | 8.70%468.2K shares | −1.10 ppfrom 9.80% | Sep 30, 2025 | SEC |
| Aug 14, 202511:54 AM ET | Woodline Partners LP | 13G/A | 9.80%518.3K shares | +4.60 ppfrom 5.20% | Jun 30, 2025 | SEC |
| Aug 13, 20252:00 PM ET | Sio Capital Management, LLC | 13G | 5.49%355.9K shares | New | Jun 30, 2025 | SEC |
| Aug 12, 20259:00 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 3.90%210.0K shares | −5.48 ppfrom 9.38%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:20 PM ET | Alyeska Investment Group, L.P.and 2 others | 13G | 9.99%530.0K shares | New | Mar 31, 2025 | SEC |
| May 15, 20251:53 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 3.90%210.6K shares | –Below 5% | Mar 31, 2025 | SEC |
| May 15, 20259:33 AM ET | Woodline Partners LP | 13G | 5.20%315.4K shares | New | Mar 31, 2025 | SEC |
| Mar 12, 20258:30 PM ET | Blatt Lawrence | 13D/A | 3.20%175.5K shares | –Below 5% | Mar 10, 2025 | SEC |
| Feb 14, 20254:56 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%188.4K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 20259:32 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 9.38%325.0K shares | – | Dec 31, 2024 | SEC |
| Feb 14, 2023 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Blatt Lawrence | 13G/AOld format | – | – | – | SEC |
| Dec 27, 2022 | Tang Capital Partners LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Janus Henderson Group PLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Baker Bros. Advisors LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Logos Global Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Beigelman Leonid | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Blatt Lawrence | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 31, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Aug 13, 2021 | Logos Global Management LP | 13GOld format | – | New | – | SEC |
| Jun 21, 2021 | Versant Venture Capital VI, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 21, 2021 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| May 3, 2021 | Versant Venture Capital VI, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Roche Finance Ltd | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 13GOld format | – | New | – | SEC |
| Feb 11, 2021 | Blatt Lawrence | 13GOld format | – | New | – | SEC |
| Feb 11, 2021 | Beigelman Leonid | 13GOld format | – | New | – | SEC |
| Jan 11, 2021 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aligos Therapeutics, Inc. shares.
No Form 144 notices for Aligos Therapeutics, Inc. are on file.